Small Molecules Enhance CRISPR Genome Editing in Pluripotent Stem Cells
Open Access
- 1 February 2015
- journal article
- research article
- Published by Elsevier BV in Cell Stem Cell
- Vol. 16 (2), 142-147
- https://doi.org/10.1016/j.stem.2015.01.003
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Self versus non-self discrimination during CRISPR RNA-directed immunityNature, 2010
- Knockout Rats via Embryo Microinjection of Zinc-Finger NucleasesScience, 2009
- CRISPR Provides Acquired Resistance Against Viruses in ProkaryotesScience, 2007
- 2,6-Disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK)Bioorganic & Medicinal Chemistry Letters, 2003
- Discovery of L-755,507: A subnanomolar human β3 adrenergic receptor agonistBioorganic & Medicinal Chemistry Letters, 1998
- A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosisHuman Molecular Genetics, 1994
- Action of brefeldin A blocked by activation of a pertussis-toxin-sensitive G proteinNature, 1992
- Assignment of the vascular smooth muscle actin geneACTSA to human chromosome 10Journal of Human Genetics, 1990
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences of the United States of America, 1985
- Studies of Adenovirus Type III Infection Treated with Methisazone and TrifluorothymidineExperimental Biology and Medicine, 1968